|4Mar 15, 9:23 AM ET

Looker Benjamin 4

4 · Esperion Therapeutics, Inc. · Filed Mar 15, 2023

Insider Transaction Report

Form 4
Period: 2023-03-14
Looker Benjamin
General Counsel
Transactions
  • Award

    Common Stock

    2023-03-14+20,50084,953 total
  • Award

    Stock Option (right to buy)

    2023-03-14+86,90086,900 total
    Exercise: $4.02Exp: 2033-03-14Common Stock (86,900 underlying)
Footnotes (2)
  • [F1]Such award will vest over a four (4) year period in equal quarterly installments, the first of which shall be on June 15, 2023, subject to continued service.
  • [F2]Such options will vest over a four (4) year period in equal quarterly installments, the first of which shall be on June 15, 2023, subject to continued service.

Documents

2 files
  • 4
    wf-form4_167888658054638.xmlPrimary

    FORM 4

  • EX-24

    LOOKER POA